Xiaoye Liu

6PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyHaematological tumoursRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Leukocyte immunoglobulin-like receptor A3 inhibits the activity of immunosuppressive myeloid cells.

|Apr 03, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer.

Xiaoye Liu, Ryan Huang, Zhiqiang Ku

|Mar 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.

Yubo He, Chengcheng Zhang, Lingxiao Tan

|May 23, 2024
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells.

Xizhen Lian, Sumanta Chatterjee, Yehui Sun

|Dec 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.

Ryan Huang, Xiaoye Liu, Jaehyup Kim

Pageof 1

Frequent Collaborators

4 joint publications

Ryan Huang

4 joint publications

Chengcheng Zhang

4 joint publications

Chengcheng Zhang

4 joint publications

Samuel John